News

Bill Anderson will stay at the helm of the pharmaceutical company until March 2029, after the supervisory board extended his ...
Bayer is a deep contrarian play, trading at less than 6x P/E, with potential for 100%+ upside if litigation risks subside.
A new study shows lower dose aspirin works to prevent bowel cancer as expert warns 'too many people are missing out on a potentially life-changing opportunity to prevent cancer' ...
Key Takeaways 1 in 6 older adults take daily aspirin to prevent heart diseaseNearly a quarter haven’t discussed their daily ...
The hot flashes and night sweats that plague breast cancer survivors during years-long hormone-suppressing therapy are eased ...
Around 1 in 6 older adults take aspirin as their primary method of preventing cardiovascular disease—despite stricter ...
Up to 15% of older adults may be routinely taking aspirin for primary prevention, and most of them understand the excess ...
Around 1 in 6 older adults take aspirin as their primary method of preventing cardiovascular disease – despite stricter ...
Around 1 in 6 older adults take aspirin as their primary method of preventing cardiovascular disease—despite stricter guidelines that no longer always call for it, a study finds.
View the latest Bayer AG (BAYN) stock price, news, historical charts, analyst ratings and financial information from WSJ.
Bayer chief executive Bill Anderson has said that newer product launches have offset the decline in sales of anticoagulant Xarelto in the first quarter, and he is confident that this will continue ...